Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects by Heejae Won, Deok Yong Yoon, Sangmi Lee, Joo‐Youn Cho, Jaeseong Oh, In‐Jin Jang, Sang‐Ku Yoo, Kyung‐Sang Yu

Connect to this object online.

Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation by Deok Yong Yoon, SeungHwan Lee, In-Jin Jang, Myeongjoong Kim, Heechan Lee, Seokuee Kim, Bongtae Kim, Geun Seog Song, Su-jin Rhee

Connect to this object online.

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study by Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, SeungHwan Lee, Kyung‐Sang Yu, In‐Jin Jang, Sang‐Ku Yoo, Youngah Kim, Jaeseong Oh

Connect to this object online.

The necessary conduct: Exploratory multiregional clinical trials in East Asia by Inseung Jeon, Yu Kyong Kim, Ildae Song, Deok Yong Yoon, Ki Young Huh, Xuanyou Jin, Kyung‐Sang Yu, SeungHwan Lee, Yuji Kumagai, In‐Jin Jang

Connect to this object online.

Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials by Sarah Kim, Rebecca J. Willcocks, Michael J. Daniels, Juan Francisco Morales, Deok Yong Yoon, William T. Triplett, Alison M. Barnard, Daniela J. Conrado, Varun Aggarwal, Ramona Belfiore‐Oshan, Terina N. Martinez, Glenn A. Walter, William D. Rooney, Krista Vandenborne

Connect to this object online.